RxDoctor Payments Data

Jim George, MD

Family Medicine · Forney, TXNPI 1619288230

Payments from drug & device makers

$5,128in general payments, 2019–2025

Across 331 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$568
  • Novo Nordisk$550
  • AstraZeneca$501
  • Merck$350
  • Pfizer$342
  • Amarin Pharma, Inc.$312
  • plus $3K from 33 others

What the payments were for

  • Food & beverage$5,128100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,128 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$139,464
Medicare patients
308
Services billed
3,101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide97$136,365
EliquisApixaban38$51,219
FarxigaDapagliflozin Propanediol36$48,482
JardianceEmpagliflozin31$39,893
JanuviaSitagliptin Phosphate21$30,326
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$26,545
TrulicityDulaglutide19$23,949
Soliqua 100-33Insulin Glargine/Lixisenatide11$21,138
SymbicortBudesonide/Formoterol Fumarate18$4,968
Gabapentin202$4,802
Levothyroxine Sodium483$4,473
Omeprazole212$4,081
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$3,475
Atorvastatin Calcium534$3,415
SynthroidLevothyroxine Sodium44$3,026

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$550$136,36597 claims
AstraZenecaFarxiga, Symbicort$501$53,44954 claims
PfizerEliquis$342$51,21938 claims
Boehringer IngelheimJardiance$207$39,89331 claims
MerckJanuvia$350$30,32621 claims
GSKTrelegy Ellipta$235$26,54525 claims
Lilly USA, LLCTrulicity$59$23,94919 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$129$21,13811 claims
AbbVieSynthroid$568$3,02644 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Forney

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →